Literature DB >> 1522825

Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells.

J R Schlehofer1, M Rentrop, D N Männel.   

Abstract

To investigate a possible role of cytokines in parvovirus-mediated suppression of tumorigenesis, we tested in cell culture whether parvoviruses are able to induce interferon (IFN)-beta, tumor necrosis factor (TNF)-alpha or interleukin-6 (IL-6). Infection of rodent or human cells with the parvoviruses minute virus of mice (MVM), H-1 or adeno-associated virus (AAV) types 2 or 5 failed to induce expression of the luciferase or beta-galactosidase reporter genes transfected into these cells as constructs containing an IFN-beta promoter. Parvoviruses did weakly induce synthesis of TNF-alpha and of IL-6 in cell culture and could slightly enhance synthesis of these cytokines when induced by other agents. These in vitro data suggest that the rather unspecific tumor-suppressive properties of parvoviruses are unlikely to be attributable to stimulation of the synthesis of IFN, TNF or IL-6.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522825     DOI: 10.1007/bf00202055

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  61 in total

1.  Transformation of established murine fibroblasts with an activated cellular Harvey-ras oncogene or the polyoma virus middle T gene increases cell permissiveness to parvovirus minute-virus-of-mice.

Authors:  S Mousset; J Cornelis; N Spruyt; J Rommelaere
Journal:  Biochimie       Date:  1986 Jul-Aug       Impact factor: 4.079

2.  Regulation of the acute phase and immune responses: interleukin-6.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  The human beta-interferon gene enhancer is under negative control.

Authors:  S Goodbourn; H Burstein; T Maniatis
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

4.  Erythrocyte association and interferon production by minute virus of mice.

Authors:  R E Harris; P H Coleman; P S Morahan
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

5.  Minute virus of mice inhibits cell transformation by simian virus 40.

Authors:  S Mousset; J Rommelaere
Journal:  Nature       Date:  1982-12-09       Impact factor: 49.962

6.  Inhibition of initiator-induced SV40 gene amplification in SV40-transformed Chinese hamster cells by infection with a defective parvovirus.

Authors:  J R Schlehofer; R Heilbronn; B Georg-Fries; H zur Hausen
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

7.  Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.

Authors:  A Ray; S B Tatter; L T May; P B Sehgal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Sensitization of transformed rat cells to parvovirus MVMp is restricted to specific oncogenes.

Authors:  N Salomé; B van Hille; N Duponchel; G Meneguzzi; F Cuzin; J Rommelaere; J J Cornelis
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

Review 9.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

10.  Firefly luciferase is targeted to peroxisomes in mammalian cells.

Authors:  G A Keller; S Gould; M Deluca; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  11 in total

1.  Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells.

Authors:  Leila N Laredj; Peter Beard
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.

Authors:  Svitlana Grekova; Rainer Zawatzky; Rita Hörlein; Celina Cziepluch; Michal Mincberg; Claytus Davis; Jean Rommelaere; Laurent Daeffler
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  H-1 parvovirus-associated replication bodies: a distinct virus-induced nuclear structure.

Authors:  C Cziepluch; S Lampel; A Grewenig; C Grund; P Lichter; J Rommelaere
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Expression profiling of human hepatoma cells reveals global repression of genes involved in cell proliferation, growth, and apoptosis upon infection with parvovirus H-1.

Authors:  Jianhong Li; Ekkehard Werner; Manfred Hergenhahn; Rémy Poirey; Zuyu Luo; Jean Rommelaere; Jean-Claude Jauniaux
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1.

Authors:  Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Andrea Baetz; Barbara Leuchs; Mandy Roscher; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

6.  Induction of an embryonic mouse innate immune response following inoculation in utero with minute virus of mice.

Authors:  Irina Rostovsky; Claytus Davis
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.

Authors:  Lisa M Mattei; Susan F Cotmore; Peter Tattersall; Akiko Iwasaki
Journal:  Virology       Date:  2013-05-12       Impact factor: 3.616

Review 8.  Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.

Authors:  Antonio Marchini; Laurent Daeffler; Vitaly I Pozdeev; Assia Angelova; Jean Rommelaere
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

9.  Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.

Authors:  Matthias Neulinger-Muñoz; Dominik Schaack; Svetlana P Grekova; Andrea S Bauer; Thomas Giese; Gabriel A Salg; Elisa Espinet; Barbara Leuchs; Anette Heller; Jürg P F Nüesch; Miriam Schenk; Michael Volkmar; Nathalia A Giese
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

10.  TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.

Authors:  Zahari Raykov; Svitlana P Grekova; Rita Hörlein; Barbara Leuchs; Thomas Giese; Nathalia A Giese; Jean Rommelaere; Rainer Zawatzky; Laurent Daeffler
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.